- Home
- SJT vs SOPH Comparison
SJT vs SOPH Comparison
Compare SJT & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SJT
- SOPH
- Stock Information
- Founded
- SJT 1980
- SOPH 2011
- Country
- SJT United States
- SOPH Switzerland
- Employees
- SJT N/A
- SOPH N/A
- Industry
- SJT Oil & Gas Production
- SOPH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SJT Energy
- SOPH Health Care
- Exchange
- SJT Nasdaq
- SOPH Nasdaq
- Market Cap
- SJT 227.0M
- SOPH 206.6M
- IPO Year
- SJT N/A
- SOPH 2021
- Fundamental
- Price
- SJT $5.76
- SOPH $3.05
- Analyst Decision
- SJT
- SOPH Strong Buy
- Analyst Count
- SJT 0
- SOPH 2
- Target Price
- SJT N/A
- SOPH $6.50
- AVG Volume (30 Days)
- SJT 259.8K
- SOPH 36.6K
- Earning Date
- SJT 05-13-2025
- SOPH 05-06-2025
- Dividend Yield
- SJT 0.40%
- SOPH N/A
- EPS Growth
- SJT N/A
- SOPH N/A
- EPS
- SJT 0.11
- SOPH N/A
- Revenue
- SJT $7,032,254.00
- SOPH $65,173,000.00
- Revenue This Year
- SJT N/A
- SOPH $14.83
- Revenue Next Year
- SJT N/A
- SOPH $22.79
- P/E Ratio
- SJT $51.23
- SOPH N/A
- Revenue Growth
- SJT N/A
- SOPH 4.49
- 52 Week Low
- SJT $3.21
- SOPH $2.58
- 52 Week High
- SJT $5.94
- SOPH $6.28
- Technical
- Relative Strength Index (RSI)
- SJT 61.70
- SOPH 41.46
- Support Level
- SJT $5.04
- SOPH $2.70
- Resistance Level
- SJT $5.94
- SOPH $3.00
- Average True Range (ATR)
- SJT 0.31
- SOPH 0.29
- MACD
- SJT 0.05
- SOPH -0.00
- Stochastic Oscillator
- SJT 87.05
- SOPH 20.22
About SJT San Juan Basin Royalty Trust
San Juan Basin Royalty Trust is an energy sector royalty trust in the United States. It owns approximately 75% net profit interest in a large number of natural gas properties in the San Juan Basin of New Mexico. About 98% of the royalties San Juan collects come from natural gas, with the balance coming from oil.
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.